UiPath, Inc. $PATH Shares Sold by Fieldview Capital Management LLC

Key Points

• Fieldview Capital cut its UiPath stake by 91.7% in Q3, selling 329,917 shares and retaining 29,843 shares valued at about $399,000.
• Insider selling accelerated: CEO Daniel Dines sold 45,000 shares and CFO Ashim Gupta sold 67,468 shares recently, with insiders offloading 832,468 shares over the past 90 days and now owning 23.19% of the company.
• Wall Street consensus is a Hold with a $15.77 price target, while UiPath shares opened at $11.61 (52‑week range $9.38–$19.84) and the company has a ~$6.21 billion market cap.

Fieldview Capital Management LLC lowered its stake in UiPath, Inc. (NYSE:PATH - Free Report) by 91.7% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 29,843 shares of the company's stock after selling 329,917 shares during the quarter. Fieldview Capital Management LLC's holdings in UiPath were worth $399,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Hudson Bay Capital Management LP purchased a new stake in UiPath during the 2nd quarter worth approximately $102,559,000. Norges Bank purchased a new position in shares of UiPath in the second quarter valued at approximately $68,451,000. AQR Capital Management LLC lifted its position in shares of UiPath by 76.0% in the second quarter. AQR Capital Management LLC now owns 11,407,569 shares of the company's stock valued at $145,732,000 after acquiring an additional 4,926,341 shares in the last quarter. TFG Asset Management GP Ltd boosted its stake in shares of UiPath by 53.3% in the second quarter. TFG Asset Management GP Ltd now owns 13,722,244 shares of the company's stock worth $175,645,000 after acquiring an additional 4,772,244 shares during the last quarter. Finally, Nomura Holdings Inc. purchased a new stake in shares of UiPath during the second quarter worth approximately $59,561,000. Hedge funds and other institutional investors own 62.50% of the company's stock.

Insider Activity

In related news, CEO Daniel Dines sold 45,000 shares of the firm's stock in a transaction dated Monday, January 26th. The shares were sold at an average price of $15.01, for a total transaction of $675,450.00. Following the completion of the sale, the chief executive officer directly owned 27,893,585 shares in the company, valued at approximately $418,682,710.85. This trade represents a 0.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Ashim Gupta sold 67,468 shares of UiPath stock in a transaction dated Monday, January 5th. The stock was sold at an average price of $16.10, for a total transaction of $1,086,234.80. Following the transaction, the chief financial officer directly owned 557,028 shares in the company, valued at $8,968,150.80. This trade represents a 10.80% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 832,468 shares of company stock valued at $13,668,235. 23.19% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several research firms recently commented on PATH. Barclays increased their price objective on UiPath from $16.00 to $18.00 and gave the company an "equal weight" rating in a research note on Monday, January 12th. Royal Bank Of Canada set a $14.00 target price on shares of UiPath in a report on Wednesday, February 11th. Evercore increased their target price on shares of UiPath from $15.00 to $17.00 and gave the company an "in-line" rating in a research report on Thursday, December 4th. Truist Financial set a $17.00 price target on shares of UiPath in a research note on Thursday, December 4th. Finally, Needham & Company LLC restated a "hold" rating on shares of UiPath in a research report on Thursday, December 4th. One equities research analyst has rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, UiPath presently has a consensus rating of "Hold" and a consensus price target of $15.77.

UiPath Stock Down 3.0%

NYSE PATH opened at $11.61 on Wednesday. UiPath, Inc. has a 52 week low of $9.38 and a 52 week high of $19.84. The business's fifty day simple moving average is $13.23 and its 200-day simple moving average is $14.01. The firm has a market cap of $6.21 billion, a PE ratio of 27.64, a P/E/G ratio of 1.64 and a beta of 1.09.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.

Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath, Inc. (NYSE:PATH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.